Literature DB >> 25339641

Identification of Sjögren's syndrome oral fluid biomarker candidates following high-abundance protein depletion.

Omer Deutsch1, Guy Krief1, Yrjö T Konttinen2, Batia Zaks1, David T Wong1, Doron J Aframian1, Aaron Palmon3.   

Abstract

OBJECTIVE: SS is an autoimmune exocrinopathy affecting ∼1 million patients in the USA that is diagnosed mostly in middle-aged women. Oral fluids (OFs) serving as the mirror of the body were suggested as an ideal non-invasive diagnostic tool. Previously we developed depletion techniques for OF high-abundance proteins to increase visualization of low-abundance proteins. Therefore the aim of this study was to examine the effect of depletion pretreatments on the identification potential of SS OF biomarker candidates.
METHODS: Unstimulated OFs were collected from 18 female SS patients and 18 healthy age- and gender-matched controls. High-abundance proteins were depleted using affinity and immunodepletion methodologies followed by semi-quantitative two-dimensional gel electrophoresis and quantitative dimethylation liquid chromatography tandem mass spectrometry (LC-MS/MS). To initially validate the MS results, western blotting was performed.
RESULTS: The use of depletion strategy before proteomics analysis increased identification ability by 3-fold. Overall, 79 biomarker candidates were identified. Proteins with the most pronounced fold changes were related to SS serum or tissue factors. In addition, bioinformatics analysis of proteins with a >3-fold increase in SS patients showed calcium-binding proteins, defence-response proteins, proteins involved in apoptotic regulation, stress-response proteins and cell motion-related proteins. Preliminary validation by western blotting of profilin and CA-I indicated similar expression profile trends to those identified by quantitative MS.
CONCLUSION: The significance of OF novel depletion methodologies is clearly demonstrated for increased visibility of biomarker candidates as well as for unveiling possible mechanisms involved in this syndrome. This represents a major contribution to our ability to use OF as a future diagnostic fluid.
© The Author 2014. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Sjögren’s syndrome; biomarker; oral fluid; protein depletion; salivary gland

Mesh:

Substances:

Year:  2014        PMID: 25339641     DOI: 10.1093/rheumatology/keu405

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  14 in total

Review 1.  The Proteomics of Saliva in Sjögren's Syndrome.

Authors:  Stergios Katsiougiannis; David T W Wong
Journal:  Rheum Dis Clin North Am       Date:  2016-06-21       Impact factor: 2.670

2.  Characterization of Human Salivary Extracellular RNA by Next-generation Sequencing.

Authors:  Feng Li; Karolina Elżbieta Kaczor-Urbanowicz; Jie Sun; Blanca Majem; Hsien-Chun Lo; Yong Kim; Kikuye Koyano; Shannon Liu Rao; So Young Kang; Su Mi Kim; Kyoung-Mee Kim; Sung Kim; David Chia; David Elashoff; Tristan R Grogan; Xinshu Xiao; David T W Wong
Journal:  Clin Chem       Date:  2018-04-23       Impact factor: 8.327

3.  Salivary Proteomics Markers for Preclinical Sjögren's Syndrome: A Pilot Study.

Authors:  Nicoletta Di Giorgi; Antonella Cecchettini; Elena Michelucci; Giovanni Signore; Elisa Ceccherini; Francesco Ferro; Elena Elefante; Chiara Tani; Chiara Baldini; Silvia Rocchiccioli
Journal:  Biomolecules       Date:  2022-05-24

4.  Resolution of co-eluting isomers of anti-inflammatory drugs conjugated to carbonic anhydrase inhibitors from plasma in liquid chromatography by energy-resolved tandem mass spectrometry.

Authors:  Marta Menicatti; Marco Pallecchi; Silvia Bua; Daniela Vullo; Lorenzo Di Cesare Mannelli; Carla Ghelardini; Fabrizio Carta; Claudiu T Supuran; Gianluca Bartolucci
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

5.  Epidermal Fatty Acid-Binding Protein: A Novel Marker in the Diagnosis of Dry Eye Disease in Sjögren Syndrome.

Authors:  Megumi Shinzawa; Murat Dogru; Seika Den; Takehiro Ichijima; Kazunari Higa; Takashi Kojima; Noriyuki Seta; Takeshi Nomura; Kazuo Tsubota; Jun Shimazaki
Journal:  Int J Mol Sci       Date:  2018-11-04       Impact factor: 5.923

6.  Phenotyping multiple subsets in Sjögren's syndrome: a salivary proteomic SWATH-MS approach towards precision medicine.

Authors:  Antonella Cecchettini; Francesco Finamore; Nadia Ucciferri; Valentina Donati; Letizia Mattii; Enza Polizzi; Francesco Ferro; Francesca Sernissi; Marta Mosca; Stefano Bombardieri; Silvia Rocchiccioli; Chiara Baldini
Journal:  Clin Proteomics       Date:  2019-06-20       Impact factor: 3.988

7.  Identification of definitive serum biomarkers associated with disease activity in primary Sjögren's syndrome.

Authors:  Ayumi Nishikawa; Katsuya Suzuki; Yoshiaki Kassai; Yuumi Gotou; Maiko Takiguchi; Takahiro Miyazaki; Keiko Yoshimoto; Hidekata Yasuoka; Kunihiro Yamaoka; Rimpei Morita; Akihiko Yoshimura; Tsutomu Takeuchi
Journal:  Arthritis Res Ther       Date:  2016-05-14       Impact factor: 5.156

Review 8.  Biomarkers for Primary Sjögren's Syndrome.

Authors:  Weiqian Chen; Heng Cao; Jin Lin; Nancy Olsen; Song Guo Zheng
Journal:  Genomics Proteomics Bioinformatics       Date:  2015-09-08       Impact factor: 7.691

9.  Standardisation of labial salivary gland histopathology in clinical trials in primary Sjögren's syndrome.

Authors:  Benjamin A Fisher; Roland Jonsson; Troy Daniels; Michele Bombardieri; Rachel M Brown; Peter Morgan; Stefano Bombardieri; Wan-Fai Ng; Athanasios G Tzioufas; Claudio Vitali; Pepe Shirlaw; Erlin Haacke; Sebastian Costa; Hendrika Bootsma; Valerie Devauchelle-Pensec; Timothy R Radstake; Xavier Mariette; Andrea Richards; Rebecca Stack; Simon J Bowman; Francesca Barone
Journal:  Ann Rheum Dis       Date:  2016-12-13       Impact factor: 19.103

Review 10.  Advancing Point-of-Care (PoC) Testing Using Human Saliva as Liquid Biopsy.

Authors:  Rabia Sannam Khan; Zohaib Khurshid; Faris Yahya Ibrahim Asiri
Journal:  Diagnostics (Basel)       Date:  2017-07-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.